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Clinics and pathology 
Disease 
Extra-nodal Marginal Zone B-cell lymphoma 
(MZBCL) of mucosa-associated lymphoid tissue 
(MALT) type, also called MALT lymphoma. 
Note 
MALT lymphomas without the t(3;14) are frequently 
associated with either a t(1;14)(p22;q32) 
(BCL10/IGH), a t(11;18)(q21;q21) (API2/MALT1, or a 
t(14;18)(q32;q21) (IGH/MALT1). 
Epidemiology 
9 cases detected to date. 
Clinics 
MALT lymphoma is an indolent disease involving 
most often the stomach, the lung, the thyroid, the 
salivary gland, the orbit, and the skin, with a non 
random anatomic distribution according to the 
translocation. The t(3;14) is frequently found in MALT 
lymphomas of the thyroid, the orbit, and the skin. 
Cytogenetics 
Additional anomalies 











Transcription factor; member of the FOXP subfamily, 








Breakpoint upstream the first 5' non coding exon of 
FOXP1. 
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